Jeffery Cauble
2021
In 2021, Jeffery Cauble earned a total compensation of $349K as Chief Financial Officer at Cesca Therapeutics, a 22% decrease compared to previous year.
Compensation breakdown
| Bonus | $95,000 |
|---|---|
| Salary | $254,000 |
| Total | $349,000 |
Cauble received $254K in salary, accounting for 73% of the total pay in 2021.
Cauble also received $95K in bonus.
Rankings
In 2021, Jeffery Cauble's compensation ranked 11,410th out of 12,415 executives tracked by ExecPay. In other words, Cauble earned more than 8.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,410 out of 12,415 | 8th |
Division Manufacturing | 5,027 out of 5,505 | 9th |
Major group Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 707 out of 801 | 12th |
Industry group Laboratory Apparatus And Analytical, Optical, Measuring, and Controlling Instruments | 187 out of 206 | 9th |
Industry Laboratory Apparatus and Furniture | 5 out of 5 | 0th |
Source: SEC filing on November 1, 2022.
Cauble's colleagues
We found one more compensation record of an executive who worked with Jeffery Cauble at Cesca Therapeutics in 2021.
2021
Chris Xu
Cesca Therapeutics
Chief Executive Officer
News
Cesca Therapeutics CEO Chris Xu's 2022 pay slips 7% to $699K
October 26, 2023
Cesca Therapeutics CEO Chris Xu's 2021 pay falls 63% to $748K
November 1, 2022
Cesca Therapeutics CEO Chris Xu's 2020 pay jumps 323% to $2M
November 5, 2021
Cesca Therapeutics CEO Chris Xu's 2019 pay falls 28% to $472K
April 21, 2020